Out-of-pocket expenditures for pharmaceuticals: lessons from the Austrian household budget survey

BackgroundPaying pharmaceuticals out of pocket is an important source of financing pharmaceutical consumption. Only limited empirical knowledge is available on the determinants of these expenditures.ObjectivesIn this article we analyze which characteristics of private households influence out-of-pocket pharmaceutical expenditure (OOPPE) in Austria.Design and methodsWe use cross-sectional information on OOPPE and household characteristics provided by the Austrian household budget survey 2009/10. We split pharmaceutical expenditures into the two components prescription fees and over-the-counter (OTC) expenditures. To adjust for the specific characteristics of the data, we compare different econometric approaches: a two-part model, hurdle model, generalized linear model and zero-inflated negative binomial regression model.FindingsThe finally selected econometric approaches give a quite consistent picture. The probability of expenditures of both types is strongly influenced by the household structure. It increases with age, doctoral visits and the presence of a female householder. The education level and income only increase the probability of OTC pharmaceuticals. The level of OTC expenditures remains widely unexplained while the household structure and age influence the expenditures for prescription fees. Insurance characteristics of private households, either private or public, play a minor role in explaining the expenditure levels in all specifications. This refers to a homogeneous and comprehensive provision of pharmaceuticals in the public part of the Austrian health care system.ConclusionsThe article gives useful insights into the determinants of pharmaceutical expenditures of private households and supplements the previous research that focuses on the individual level.

[1]  E. Norton Out-of-Pocket Health Care Expenditures , 2005 .

[2]  Jean-Paul Chaze Assessing household health expenditure with Box-Cox censoring models. , 2005, Health economics.

[3]  What Drives Individual Health Expenditure in Switzerland? , 2008 .

[4]  N. Sheibani,et al.  Paris , 1894, The Hospital.

[5]  Nigel Rice,et al.  HEALTH ECONOMETRICS , 2018 .

[6]  Michael Razen,et al.  The "Inflow-Effect" - Trader Inflow and Bubble Formation in Asset Markets , 2014 .

[7]  M. Sutter,et al.  Donations, Risk Attitudes and Time Preferences: A Study on Altruism in Primary School Children , 2015, SSRN Electronic Journal.

[8]  Maik H. Wolters,et al.  Estimating the impact of climate change on agricultural production: accounting for technology heterogeneity across countries , 2014 .

[9]  P. Tsakloglou,et al.  Modelling health expenditure at the household level in Greece , 2009, The European Journal of Health Economics.

[10]  P. Contoyannis,et al.  The impact of public voluntary health insurance on private health expenditures in Vietnam. , 2003, Social science & medicine.

[11]  Wolfgang A. Brunauer,et al.  Statistical Risk Analysis for Real Estate Collateral Valuation using Bayesian Distributional and Quantile Regression , 2014 .

[12]  Johann Scharler,et al.  Total factor productivity and the propagation of shocks: Empirical evidence and implications for the business cycle , 2016 .

[13]  P. Deb,et al.  Estimates of use and costs of behavioural health care: a comparison of standard and finite mixture models. , 2000, Health economics.

[14]  Melinda Beeuwkes Buntin,et al.  Too much ado about two-part models and transformation? Comparing methods of modeling Medicare expenditures. , 2004, Journal of health economics.

[15]  M. Grossman On the Concept of Health Capital and the Demand for Health , 1972, Journal of Political Economy.

[16]  Han Bleichrodt,et al.  Handbook of Health Economics , 2001 .

[17]  Kurt Hornik,et al.  Home victory for Brazil in the 2014 FIFA World Cup , 2014 .

[18]  A. Wagstaff,et al.  The demand for health: an empirical reformulation of the Grossman model. , 1993, Health economics.

[19]  W. Manning,et al.  The demand for prescription drugs as a function of cost-sharing. , 1985, Social science & medicine.

[20]  Gottfried Tappeiner,et al.  The Multiple Facets of Regional Innovation , 2014 .

[21]  James C. Cox,et al.  What is trustworthiness and what drives it? , 2014, Games Econ. Behav..

[22]  P. Deb,et al.  Demand for Medical Care by the Elderly: A Finite Mixture Approach , 1997 .

[23]  A. Figueiras,et al.  Sociodemographic factors related to self-medication in Spain , 2004, European Journal of Epidemiology.

[24]  E. Norton,et al.  Behavioral Implications of Out-of-Pocket Health Care Expenditures , 2006 .

[25]  E. Theurl,et al.  What drives out-of pocket health expenditures of private households? - Empirical evidence from the Austrian household budget survey , 2014 .

[26]  Carmen Arguedas,et al.  On fraud and certification of corporate social responsibility , 2014 .

[27]  H. Brenner,et al.  Inequalities in out-of-pocket payments for health care services among elderly Germans – results of a population-based cross-sectional study , 2014, International Journal for Equity in Health.

[28]  Joan Costa-Font,et al.  Determinants of out-of-pocket pharmaceutical expenditure and access to drugs in Catalonia , 2007 .

[29]  H. Ostermann,et al.  Austria: Health System Review. , 2018, Health systems in transition.

[30]  Mei Wang,et al.  Behavioral determinants of home bias - theory and experiment , 2014 .

[31]  E. Theurl,et al.  Atypical Employment and Health: A Meta-Analysis , 2014 .

[32]  W. Manning,et al.  Estimating Log Models: To Transform or Not to Transform? , 1999, Journal of health economics.

[33]  J. Qiu,et al.  Car mechanics in the lab : investigating the behavior of real experts on experimental markets for credence goods , 2014 .

[34]  E. Savage,et al.  The Distribution of Household Health Expenditures in Australia , 2008 .

[35]  E. Theurl Reform of hospital financing in Austria: successes, failures, and the way forward , 2015, The European Journal of Health Economics.

[36]  R. Kerschbamer,et al.  How the value of information shapes the value of commitment or why the value of commitment does not vanish , 2014 .

[37]  U. Gerdtham Equity in health care utilization: further tests based on hurdle models and Swedish micro data. , 1997, Health economics.

[38]  A. Zeileis,et al.  Innovation and institutional ownership revisited: an empirical investigation with count data models , 2016, Empirical Economics.

[39]  J. S. Silva,et al.  Two-part multiple spell models for health care demand , 2001 .

[40]  E. Dutcher,et al.  To mitigate or to adapt? Collective action under asymmetries in vulnerability to losses , 2014 .

[41]  S. Borsky,et al.  Setting one voluntary standard in a heterogeneous Europe - EMAS, corruption and stringency of environmental regulations , 2014 .

[42]  M. Kirchler,et al.  Friendliness pays off! Monetary and Immaterial Gifts in Consumer-Salesperson Interactions , 2014 .

[43]  F. Dobbels,et al.  Assessing the Impact of Tiotropium on Lung Function and Physical Activity in GOLD Stage II COPD Patients who are Naïve to Maintenance Respiratory Therapy: A Study Protocol , 2011, The open respiratory medicine journal.

[44]  Winfried Pohlmeier,et al.  An Econometric Model of the Two-Part Decisionmaking Process in the Demand for Health Care , 1995 .

[45]  T. Schober,et al.  Follow Your Heart: Survival Chances and Costs after Heart Attacks—An Instrumental Variable Approach , 2017, Health services research.

[46]  Matthias Sutter,et al.  Experimental Games on Networks: Underpinnings of Behavior and Equilibrium Selection , 2014, SSRN Electronic Journal.

[47]  U. Dulleck,et al.  Too Much or Too Little? Price Discrimination in a Market for Credence Goods , 2014, Journal of Institutional and Theoretical Economics.

[48]  P. Grootendorst,et al.  A comparison of alternative models of prescription drug utilization. , 1995, Health economics.

[49]  James M. Walker,et al.  Externalities in appropriation: responses to probabilistic losses , 2017, Experimental economics.

[50]  M. Perlman,et al.  Health, Economics, and Health Economics , 1983 .

[51]  Mei-Chen Hu,et al.  Zero-Inflated and Hurdle Models of Count Data with Extra Zeros: Examples from an HIV-Risk Reduction Intervention Trial , 2011, The American journal of drug and alcohol abuse.

[52]  E. Theurl,et al.  Out-of-pocket expenditure by private households for dental services – empirical evidence from Austria , 2016, Health Economics Review.

[53]  Alex Kupfer,et al.  The impact of liquidity on inflation-linked bonds : A hypothetical indexed bonds approach ∗ , 2014 .

[54]  P. Trivedi,et al.  Economics of self-medication: theory and evidence. , 2003, Health economics.